Purpose: To develop a continuous-infusion dynamic MRI technique to characterize tumor-associated microvascular proliferation (MVP) in a rat brain model of glioblastoma multiforme. Methods: The proposed model assumes effects due to tumorassociated MVP (eg, vascular permeability, K trans ; intravascular plasma fraction, v p ) cannot be individually separated and solves for a single parameter (k vasc ) that quantifies the T 1 -weighted contrast enhancement from dynamic images acquired during continuous contrast agent (CA) infusion. Untreated C6 tumor-bearing animals (N ¼ 6) were serially imaged on postoperative days (PODs) 14 and 18 with a 3 Tesla clinical scanner utilizing a dynamic spatial and temporal resolution of 0.38 Â 0.38 Â 1.5 mm 3 and 3.47 s, respectively. 
INTRODUCTION
Glioblastoma multiforme (GBM) is the most common and most malignant primary brain tumor in adults (1) . A key histologic feature of GBM that is absent in normal brain tissues is the occurrence of microvascular proliferation (MVP). Compared to normal cerebral vessels, GBM vasculature has been associated with increased microvessel density (2) , high variability in vessel diameter (3) , and greater tortuosity (4) . The accompanying tight junction formation also is incomplete and results in a compromised blood-brain barrier (ie, increased permeability), leading to edema and the extravasation of contrast agents into the extravascular extracellular space (EES) during imaging studies of GBM (5-7). Microvascular proliferation (MVP), as measured by contrast enhancement during radiologic evaluations of GBM, has a central role in the diagnosis of new, residual, and recurrent tumors (8) (9) (10) . Extent of contrast enhancement has been associated with worse clinical outcomes (11) (12) (13) , whereas therapies directed at normalization of the vascular structure and function tend to improve progression-free survival (14) . As new therapies emerge, quantitative imaging methods for the longitudinal evaluation of microvascular-associated attributes may provide mechanistic evidence of efficacy in animal models of GBM prior to usage in clinical trials.
Different pharmacokinetic models that describe the dynamic T 1 -weighted contrast enhancement in the brain have been proposed (15) (16) (17) . Algorithms based on the bolus delivery of contrast agents (CAs) largely have been utilized during the imaging of human brain neoplasms to measure the endothelial transfer rate constant (K trans ), EES volume fraction (v e ), intravascular plasma fraction (v p ), and the CA reflux rate constant (k e ) (18) (19) (20) . Yet, the abnormal structure and function inherent to tumorassociated MVP poses the risk of under-or overestimation of parameters during attempts to parse contributions between permeability and microvascular structure. Studies have attempted to overcome this limitation by restricting models to first-pass effects during bolus administration of contrast, which has been shown to yield a lower estimate of permeability compared to approaches that utilize the full complement of acquired data points (21) . However, temporal resolution of dynamic images ($5 s), coupled with a bolus infusion of the CA ($4 s), requires either an iterative fitting of nonlinear multi-parametric curves with relatively few points that may be susceptible to trapping in a local minimum (22) , or the inclusion of additional data points that extend beyond first-pass effects to provide model stability yet also reintroduce interactions between permeability and microvascular structure that the first-pass effect model originally sought to avoid (23) . Regardless of approach, multi-parameter models have been shown to yield results across all parameters that vary widely by analytical method (24) , supporting previous observations regarding the complexity and uncertainty of separating tumor-associated contrast enhancement into component parts (25) .
Beyond the potential limitations associated with pharmacokinetic models, application of dynamic T 1 -weighted contrast enhancement techniques in animal models of GBM presents several technical challenges, particularly on clinical scanners. First, temporal and spatial resolution balanced with signal-to-noise ratio (SNR) has largely driven dynamic acquisitions of the rat brain toward small-bore, high field-strength (ie, 4.7-12 Tesla (T)) animal-specific systems (26) (27) (28) (29) (30) . The few applications that have occurred on clinical-strength magnets (ie, 3T) required compromise of either spatial (31) or temporal (32) resolution. Second, use of custom-made animal coils may improve SNR on clinical magnets (33, 34) , but implementation of solenoid coils for consistent SNR throughout the brain requires orthogonal positioning of the animal relative to the main magnetic field. As a consequence, bolus injection of paramagnetic CAs induces susceptibility artifacts in vessels desirable for measurement of the arterial input function (AIF) (ie, carotid arteries, superior sagittal sinus (SSS)) and disruption of signal from adjacent tissues (35) . Finally, the identification of a suitable AIF during small animal imaging must consider the relatively large in-plane and through-plane acquisition resolutions that are vulnerable to partialvoluming effects attributable to size and vessel tortuosity, respectively. As alternatives to measuring plasma CA concentration ([CA]) in intracranial vessels, previous studies have employed standard models of the AIF (36), multi-coil arrangements for concomitant monitoring of contrast arrival in the heart (26) , and reference regions models (RRMs) (29) . Although the implementation of the latter method has previously introduced an additional variable (ie, reference tissue permeability) to resolve during curve-fitting, the RRM approach permits variability associated with CA infusion between animals while removing the dependence on vessel identification.
In this study, a continuous infusion dynamic T 1 -weighted contrast enhancement model adapted from the Brix method (17) is proposed. The model assumes that intravoxel enhancement represents tumor-associated MVP with abnormal structure and function that cannot be effectively separated. As such, the consequent voxelbased parameter determination derived from tumorassociated dynamic contrast enhancement is denoted k vasc to distinguish from multi-parametric models that utilize the more conventional K trans notation (37) . The model also introduces a muscle-based RRM to estimate the AIF required during parameter fitting for a continuous infusion of contrast. Finally, the technique is employed to monitor the effects of MVP in a rat brain tumor model of GBM on a 3T clinical scanner utilizing a comparable spatial and temporal resolution during dynamic imaging as small-bore, high field-strength, animal magnets.
THEORY
The proposed two-compartment model is an adaptation of the Brix method (17) that uses a continuous infusion of a CA. The differential equations to describe the mass balance of the model (Fig. 1 ) in tissues and vessels with normal structure and function are:
where K trans (min À1 ) is endothelial permeability; C p (mM) and C t (mM) are the [CA] in the vascular space and tumor tissue, respectively; K in (mM/min) is the amount of CA being infused over a fixed interval at a constant rate; and K e (min À1 ) is the rate of CA elimination from the plasma volume either through excretion or distribution in tissues. Assuming the reduction of CA from plasma due to lesion loss is insignificant relative to the loss from the excretion or distribution of CA in other tissues (ie, C p K trans < < C p K e ), an assumption present in both bolus-based methods (16) and the original Brix method (17), Equation [1] simplifies to:
Solving these differential equations, [2] and [3] , with the initial conditions C p ð0Þ ¼ 0 and C t ð0Þ ¼ 0, yields: respectively. Assuming fast exchange conditions and a linear relationship between the reciprocal of the longitudinal relaxation rate of tissue and CA (16, 38, 39) , the equation for a spoiled gradient echo (SPGR) sequence is:
where G is the gain; PD is proton density; R EðtÞ ¼ SðC t Þ À Sð0Þ Sð0Þ [7] with Equation [6] In addition, utilizing dynamic data points acquired only during a relatively fast continuous infusion of CA (eg, < 30 s) for parameter determination minimizes the nonlinear effects associated with fast exchange limit disruption due to the interactions between intravascular, interstitial, and intracellular water components (41) . Although K trans in healthy tissues represents permeability, intravoxel contrast enhancement in tumor-associated MVP may be attributable to loss of the vascular function, atypical structure, or both. As such, K trans will subsequently be designated as k vasc in the context of abnormal tissues to reflect the model-associated derivation, while also recognizing the ambiguity and complexity in signal origin inherent to MVP.
The identification in the rat brain of a suitable AIF to measure C p from Equations [6] and [7] is challenging, as described above. From a spatial-resolution perspective, the SSS represents a viable target; however, factors that affect intracranial pressure (eg, positioning, tumor mass effect, and edema) may alter blood flow, causing variable baseline signal intensity not only between animals but also from different slices of the SSS within the same animal. Monitoring contrast enhancement in muscle offers an alternate means to estimate [CA] [5] by minimizing the sum of squares, Q, between muscle and vascular imaging data, S m and S v , respectively; and the calculated fit values, T m and T v , respectively:
where
The coupling of muscle and vascular data is necessary to: 1) prevent unconstrained fitting of muscle data, which is associated with K in and K e values that yield C p curves inconsistent with observed imaging changes; and 2) determine the number of data points, N, to include in Equation [8] because C t in muscle will continue to rise even after C p begins to decay. The scaling factor w v biases the minimization of Q toward the fit of muscle data while preserving physiologic values of K in and K e . Of note, K in can be estimated directly based on rate of infusion and calculated plasma volume; however, the fitting of K in may provide a better estimate due to variations in mixing associated with animal positioning, location of intravenous catheter insertion site in the tail vein, manual injection, and cardiac output.
METHODS

Phantoms
Normal Saline (NS) Phantom
Gadopentetate dimeglumine (Gd-DTPA; Bayer HealthCare; 0.5 M) was prepared in NS at concentrations of 2, 1, 0.5, 0.25, 0.125, and 0 mM. Each dilution maximally filled a single well in a 24-well plate, and all wells were subsequently sealed with a plastic adhesive to prevent evaporation and maintained at 37 C in a water bath until imaging.
Muscle Phantom
Fresh lean bovine muscle (1.5 g) was placed in 50-mL dilutions (2, 1, 0.5, 0.25, 0.125, and 0 mM) of Gd-DTPA in NS for 10 hours with gentle agitation at 4 C. Dilutions were removed and replaced for an additional 2 hours of incubation with gentle agitation at 4 C. Muscle was removed and placed in a 24-well plate containing a fresh, corresponding dilution and brought to 37 C in a water bath prior to imaging. During phantom imaging experiments at 37 C, temperature was maintained by placing the phantom on an isothermal pad (Deltaphase, Braintree Scientific, Inc., Braintree, MA).
Cell Culture
The C6 cell line was established from a glioma generated by intravenous exposure of random-bred Wistar-Furth rats to N,N'-nitrosomethylurea (45) and is a wellrecognized model of glioma in rats. Cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco, Gaithersburg, MD) with 5% fetal bovine serum and 100 mg/mL penicillin/streptomycin and 50 mg/mL gentamycin in a humidified incubator at 37 C in 5% CO 2 .
Animal Procedures
All animal procedures were approved by the University of Washington Internal Animal Care and Use Committee prior to study initiation. Twelve adult male Wistar rats (Charles River Laboratories, Wilmington, MA) were used in this study: six healthy rats and six rats serially imaged on postoperative day (POD) 14 (baseline) and POD 18 (follow-up) after intracranial inoculation with C6 cells. Stereotactic intracranial implantation of 10 6 C6 cells suspended in 10 mL of DMEM was consistent with previously described procedures (46) .
For imaging experiments, animals were induced in an anesthesia chamber with 5% isoflurane mixed with oxygen and subsequently maintained on 2% isoflurane mixed with oxygen via nose cone inhalation. Immediately prior to imaging, a 22-gauge angiocatheter (BectonDickinson, Sandy, UT) was inserted into the tail vein. The catheter was attached to a small-bore bifurcated extension (Smiths Medical, Dublin, OH) containing a dilution of Gd-DTPA in one arm and a NS flush in the other. The catheter setup was maintained with a saline lock until dynamic imaging. During catheter insertion and imaging, animals were placed on an isothermal pad (Deltaphase) to maintain core body temperature.
On the final day of imaging, animals were anesthetized with 2 mL/kg Beuthanasia-D and then euthanized by intravascular perfusion of the animal with 4% paraformaldehyde (PFA) via an open-chest, left cardiac ventricle puncture approach. Brains were removed intact and underwent a secondary fixation in 4% PFA for 24 hours before being placed in 70% ethanol.
MRI Acquisition
All imaging experiments were performed on a 3T wholebody clinical scanner (Philips Achieva, Philips Medical Systems, Best, Netherlands). A transmit/receive (T/R) head coil (Philips Medical Systems) was used for radiofrequency (RF) transmission and reception during phantom imaging. During animal imaging, a dual-coil approach was utilized, as previously described (46) , that combined the T/R head coil for transmit and a custombuilt combined solenoid-surface coil (34) for RF reception. The combined solenoid-surface coil required that the animal was placed orthogonal to the scanner gantry.
T 1 Phantom Measurements
Images from an inversion recovery 2D spin echo (SE) sequence (repetition time/echo time (TR/TE) ¼ 6000/10 ms) with echo train length (ETL) ¼ 13 and 16 intervals (50, 75, 100, 150, 200, 300, 400, 600, 800, 1000, 1200, 1600, 2000, 3000, 4000, and 5000 ms) were used to measure T 1 . Additional parameters included field-of-view (FOV) ¼ 140 Â 140 mm 2 , matrix ¼ 140 Â 130, acquisition resolution ¼ 1.00 Â 1.08 Â 2.00 mm 3 (zero-interpolated to 0.49 Â 0.49 Â 2.00 mm 3 ), and number of excitations (NEX) ¼ 2.
T 2 Phantom Measurements
Images from a 2D SE sequence (TR ¼ 3000 ms, a ¼ 90 ) . Coincident with the start of the fourth dynamic scan, Gd-DTPA was manually injected at 50 mL/s, followed by a 250-mL injection of NS at 50 mL/s. Control animals were injected with either 0.1 (N ¼ 3) or 0.2 (N ¼ 3) mmol/kg (0.084 and 0.167 M/L, respectively) of Gd-DTPA. All tumor-bearing animals were injected with 0.2 mmol/kg of Gd-DTPA. Total time for injection of Gd-DTPA and the NS bolus for all animals was < 20 seconds. Precontrast R 1 maps and postcontrast R 1 maps obtained 5 minutes after CA injection were acquired using the variable flip angle (VFA) method (47) with a 3D SPGR sequence (TR/ TE ¼ 4.6/20 ms) utilizing a ¼ 4 
Tumor Identification
Fast bound pool fraction imaging was utilized for high spatial-resolution tumor identification, as previously described (46) . Total scan time to produce f maps was 45.5 minutes.
Image Processing
Phantoms T 1 and T 2 measurements were obtained from region-ofinterest (ROI) data. For each Gd-DTPA concentration ([Gd]), T 1 data were fit to SIðT I Þ ¼ r 0 ð1 À 2e ÀTI =T1 Þ, where SI ¼ signal intensity, r 0 ¼ spin density, and T I is inversion time. R C 1 was subsequently measured using a linear least-squares fit to the coordinates ([Gd], 1/T 1 [Gd] ). T 2 data were fit to SIðT E Þ ¼ r 0 e ÀTE =T2 , where T E is time to echo. R C 2 was subsequently determined using a linear least-squares fit to the coordinates ([Gd], 1/T 2 [Gd]).
Animals
Pre-and postcontrast R 1 maps (R 1 ¼ 1/T 1 ) were reconstructed from the corresponding VFA data using a leastsquares linear fit to the signal intensities (S) transformed into the coordinates (S(a)/sina, S(a)/tana) (47). Voxelbased [Gd] maps were determined from: 
FIG. 4.
Measuring the effects of Gd-DTPA in the superior sagittal sinus (SSS) and muscle in rats without tumors. Precontrast coronal images (A-F) of the rat brain displayed at a uniform window and level setting. The signal in the SSS (A-F, white arrow) is variable in all six animals ranging from absent to hyperintense. In G, the normalized signal intensity of the SSS after administration of Gd-DTPA (lower case letters correspond to animals A-F; curve (a) and (*) represent different slices from the same animal). In H, the mean ( 6 SD) normalized signal intensity in the SSS at each dose is represented. In I, the normalized signal intensity from muscle adjacent to the calvarium is shown (lower case letters correspond to animals A-F). In J, the mean ( 6 SD) normalized signal intensity from muscle for each dose of Gd-DTPA is depicted. À1 and the mean longitudinal relaxation rate of muscle (R 1m ), determined by the average value from all control animals, voxel-based k vasc maps in tumor-bearing animals were subsequently computed by the following two steps: 1) Using Equation [8] , K in and K e were determined for each animal with the mean SI from ROIs within the temporalis muscle and constraining the fit to a standardized plasma concentration curve (C p ), defined by K in and K e and scaled to C p (20.8); and 2) k vasc maps were constructed from a voxelbased fit of dynamic MR images using Equations [6] and [7] , in which S(0) was the median value from the images prior to CA arrival. B 1 maps were used to correct the voxel-based excitation flip angles for both the VFA and dynamic MRI datasets (Fig. 2) .
Tumors were manually outlined using [Gad] maps. Tumor subregions were also manually outlined based on apparent visual incongruences between k vasc and [Gd] maps. All image processing was performed using inhouse written MatLab (MathWorks, Natick, MA) and C/ Cþ þ language software.
Histology
After fixation, brains were embedded in paraffin, sectioned (5-mm thick), and stained with hematoxylin and eosin. Slides were scanned using an Olympus VS110 virtual microscopy system (Olympus, Center Valley, PA) for display on NDP.view (v2.5.14).
Statistical Analysis
For continuous variables, the mean and standard deviation (SD) were calculated. The Student independent t test assuming equal or unequal variance based on Levene's test was used to compare mean values between groups. Pearson's correlation coefficient (r) was used to identify associations between parameters. Statistical analyses were performed with SPSS for Windows (Version 12.0, SPSS, Chicago, IL). Statistical significance was defined as P < 0.05. (Fig. 3) .
RESULTS
Measurement of Gd
Determination of Standardized Plasma [Gd] Curve for the Muscle-Based RRM
The signal intensity in the SSS prior to infusion of CA was variable (Figs. 4 A-F) . The normalized signal intensity (NSI) in the SSS during infusion of either 0.1 and 0.2 mmol/kg of Gd-DTPA was also variable (Figs. 4G-H) . In contrast, NSI from the temporalis muscle segregated based on dosage of Gd-DTPA (Figs. 4I-J). Of note, the NSI in the SSS plateaued at t ¼ 20.8 s, whereas the NSI in muscle continued to increase (Figs. 4G and 4I). As such, seven data points (ie, N ¼ 7 for Eq. [8] ) were used for all subsequent animal-derived curve-fitting to represent the period of continuous infusion. The mean ( 6 SD) R 1 for muscle from all six control animals was R 1m ¼ 0.63 6 0.03 s À1 and was used for all subsequent calculations. Determining K in and K e solely from muscle data yielded strong fits to muscle data, but the reconstructed plasma curve (C p ) based on these values did not correspond with the general shape of the observed variations in NSI from plasma during the continuous infusion of Gd-DTPA (Fig. 5) . To provide a C p (t) input for the constrained fitting described in Equation [8] , C p (t) was estimated by utilizing Equation [4] , setting K trans m ¼ 0.1 min
À1
, and assuming a linear increase in plasma [Gd] to approximate C p (t) at t ¼ 20.8, which was followed by scaling the NSI from the SSS accordingly. The K in and K e values produced from this approach provided plasma curves that were consistent with observed increases in NSI (Figs. 6A-F ). There was a significant difference in the ratio K in /K e between animals given a full dose versus a low dose (3.41 6 0.26 vs. 2.14 6 0.26 mM, respectively; P ¼ 0.007), which was consistent with the proposed model.
A NSI from the SSS for the constrained fit of muscle data may not be reliably detected in all tumor-bearing animals, particularly when large tumors occur. Accordingly, a standard plasma curve (C p ) based on the mean K in (25.1 6 8.8 mM/min À1 ) and K e (7.3 6 2.1 min À1 ) and scaled to the mean value of C p (20.8) ¼ 3.10 6 0.51 mM, FIG. 5. Determination of K in and K e using only muscle data. Although the overall fit (C t , gray solid line) to the muscle data (gray squares) is strong, the shape of the theoretical blood curve (C p , black solid line) applying the determined K in and K e to Equation [5] does not match well to the observed blood signal (black circles).
which was determined from the 0.2 mmol/kg dosage group, was generated. Differences in plasma curves and fitted data for both muscle and plasma are depicted in Figure 6 (G-I). There was not a significant difference in determination of K in /K e using the standard curve compared to individual curves (3.25 6 0.18 vs. 3.41 6 0.26 mM, respectively; P ¼ 0.49). Subsequently, these parameters (K in ¼ 25.1 mM/min À1 , K e ¼ 7.3 min À1 , and scaling factor of C p (20.8) ¼ 3.10 mM) were used during the constrained fit of muscle data in tumor-bearing animals during voxel-based determination of k vasc .
Tumor Imaging
Tumor phenotypes on f maps were consistent with morphologies on histology (Figs. 7 and 8 vasc were also present (0.45 < r < 0.82, P < 0.001) (Figs. 9 and 10 ). However, subregions within each tumor at follow-up demonstrated an absence of association between intratumor [Gd] and intratumor k vasc (N ¼ 5; -0.08 < r < 0.22, P > 0.05) (Figs. 9A and C, Figs. 10A-C) , or the association became inverted (N ¼ 1; r ¼ -0.28, P ¼ 0.001) (Fig. 9B ). These latter findings indicated the presence of differences within tumors between locations of blood-brain barrier disruption and the subsequent pooling of CA. A consistent underlying microscopic tissue appearance to explain the discordance was not present (Supporting Figs. S2 and S3 ).
FIG. 6. Solid lines (A-
) represent the fitted curves for muscle (gray) and blood (black) for each determination of K in and K e from the fulldose (A-C) and half-dose (D-F) animals using Equation [8] to constrain the fit of muscle data (gray squares) to the general shape of the blood data (black circles). Note that the fit to muscle data is strong while providing K in and K e values that yield a blood curve consistent with observed imaging data. In G-I, dashed lines have been added to the plots from the full-dose animals (A-C), which represent the fitted curves for muscle (gray) and blood (black) using the standardized blood data (black diamonds) derived from the average values of K in and K e , individually measured from the full-dose animals to constrain the fit of muscle data.
DISCUSSION
In this study, a model based on the continuous infusion of a CA and the accompanying temporal T 1 -weighted variations in contrast enhancement was implemented for the serial evaluation of tumor-associated blood-brain barrier permeability changes in an animal model of GBM. In 1991, Brix et al. proposed the continuous infusion model to describe the kinetics of contrast enhancement in the brain (17) . The model utilized data points during and after the infusion as part of a nonlinear fitting of three parameters: 1) k 21 , the rate constant for transfer of contrast from the EES back into the central compartment; 2) k el , the rate constant for elimination of contrast from the central compartment; and 3) A, which was dependent on the tissue, sequence parameters, and infusion rate (17) . Subsequent application of the continuous infusion technique in the brain, however, was largely limited to a single publication (49) . Wider implementation may have been limited, at least in part, due to a study by Tofts and Berkowitz that compared continuous-infusion models to bolus-infusion models and found the latter was more efficient and easier to administer (50) . A critical difference between the methodology described herein and previous applications of the continuous infusion model was infusion time. The infusion time utilized in the present study ( < 20 s) was substantially shorter than that used by Brix et al. (50)). Longer continuous infusion times lead to reduced tissue enhancement compared to a bolus infusion (50) and permit the occurrence of intervoxel diffusion that may confound results (51) . In the present study, these potential effects were mitigated by a relatively short infusion time and rapid image acquisition FIG. 8. Serial parametric maps from POD 14 and POD 18 with corresponding histology from POD 18 of rat brain tumors. On f maps, the tumors (white arrowheads; A-C) appeared hypointense compared to surrounding gray matter. White matter structures (eg, see A: AA, CC) were hyperintense. Tumor phenotypes were consistent with the morphology on histology (magnifications shown in insets). Tumors either grew outward from along the injection track (A) or were well-circumscribed bulky lesions (B and C). In A, the strongest increase in k vasc (white arrow) was disparate from the accumulation of contrast (black arrow), which was inferiorly located. By POD 18, there were two distinct elevations in k vasc (white arrows), whereas the general distribution of contrast accumulation remained similar (black arrow). In B, the accumulation of contrast (POD 18, black arrow) was largely derived from an inferior-based vascular network, as evidenced by the k vasc map (white arrow). In C, there was relatively minor change in the overall accumulation of contrast between time points (black arrows), which was mirrored by the relatively stable k vasc values and distribution (white arrows). Window and level for each parametric map are identical in all corresponding images for Figures 7 and 8 . The black bar in the bottom right corner of each histology inset represents a length of 1 mm. AA, anterior limb, anterior commissure; CC, corpus callosum; H&E, hematoxylin and eosin stain; POD, postoperative day.
during dynamic scanning that yielded seven data points for model fitting of only a single parameter. This approach produced longitudinal parametric maps of permeability that identified a range of values within and between tumors, including differences and similarities between increased blood-brain permeability and CA accumulation.
The implementation of a RRM as a surrogate for a vascular-based AIF has several advantages. First, the use of a reference point from extracranial healthy tissue (ie, muscle) avoids tumor-associated effects (eg, increased intracranial pressure, edema) that may confound parameter determination during the study of intracranial tumors. In addition, the use of a RRM may afford the opportunity to more directly compare results derived from different methods that yield incongruent results. In a subcutaneous model of adenocarcinoma, Yankeelov Figure 7 . The tumor was outlined in blue based on appearance on the [Gd] map, whereas subregion within each tumor was outlined in yellow. Scatter plots are shown for the tumor (blue þ blue/yellow dots) and each subregion (blue/yellow dots). The solid blue line and solid yellow line correspond to the best linear fit through the tumor and the subregion, respectively. The associated Pearson's r value and P value correspond to the colors of the solid lines.
to gain the advantage of preserving model stability and introducing a reference scale for comparison of k vasc values. An additional benefit of the RRM is that a standard intravascular distribution of contrast agent is not assumed. Although Ng et al. found that pharmacokinetic parameters are not substantially altered using a common AIF versus individually measured AIFs (24), the common AIF employed by Ng et al. was derived from the mean of the individual AIFs. Furthermore, different types of AIFs have been described, and the selection of different functions has been shown to effect parameter determination (52) . Accordingly, the effects on parameter determination of using a standardized AIF across multiple studies that may vary in methodology remains unclear. Therefore, a strength of RRMs is the opportunity to account for the interanimal variability inherent to contrast infusions due to heart rate and contrast delivery, while concomitantly optimizing the modeling of the AIF.
Spatial and temporal resolution are critical aspects of dynamic imaging. Utilizing an accelerated temporal resolution of 4.97 s in patients with abdominal or pelvic masses, Parker et al. found the AIF associated with a bolus injection as a first-pass peak followed by a recirculation peak and then a washout period (53) , which was distinctly different from the commonly used monotonically biexponential decay AIF (54) . Differences between the modeled AIF were subsequently shown to cause statistically significant differences in the determination of K trans , v p , and v e (53) . In this study, the high temporal resolution of 3.47 s enabled sufficient acquisition of data points during a continuous, albeit rapid, infusion of contrast for determination of a single parameter, k Figure 8 . The tumor was outlined in blue based on appearance on the [Gd] map, whereas a subregion within each tumor was outlined in yellow. Scatter plots are shown for the tumor (blue þ blue/yellow dots) and each subregion (blue/yellow dots). The solid blue line and solid yellow line correspond to the best linear fit through the tumor and the subregion, respectively. The associated Pearson's r value and P value correspond to the colors of the solid lines.
dynamic imaging on small-bore animal magnets (range: 6.3-9.4T) using a similar temporal resolution (range: 2-4.8 s) has spanned from 0.27 Â 0.27 Â 1.5 to 0.33 Â 0.33 Â 2.0 mm 3 (27, 29, 36, 55) . The similarity in acquisition parameters without sacrificing apparent image quality between the study described herein and investigations conducted at higher field strengths supports the assertion by Pillai et al. that specialized coils may allow greater accessibility to animal-based MRI studies at centers without animal scanners (33) .
Several elements of the study design merit consideration. First, the specific approach for determining the relaxivities of the CA in muscle has not been previously described. The measurement is dependent on the passive diffusion of CA throughout the EES of muscle. This assumption is supported by early studies of the bloodbrain barrier in which brain tissue and muscle were incubated with various substances to measure permeability, and muscle was utilized as the reference tissue for maximum diffusion (56) . As such, alternative strategies to determine R C 1 and R C 2 in muscle may yield different values and alter the subsequent estimation of k vasc . Second, the proposed continuous infusion approach was not compared to an existing bolus-based methodology. Identifying a specific parameter to evaluate potential associations between methods is limited by the underlying premise of the current model that the individual effects of the abnormal tumor-associated MVP (ie, K trans , v p , and v e ) are inseparable and collectively represented by k vasc . In addition, simulating bolus-based methods requires assumptions that conflict with the current model. Specifically, commonly used bolus-based methods such as the modified Kety-Tofts model (a three-parameter model that assumes bidirectional transfer of CA) (39):
or the Patlak model (a two-parameter model in which the efflux of CA from the EES back into the vascular space is assumed to be negligible) (57):
define v p based on the first image acquired in correspondence with maximum signal intensity on the AIF (AIFmax ). However, determination of v p is affected by bolus delivery timing and dynamic acquisition time in conjunction with both vascular structure and K trans . Accounting for effects prior to AIF max affects the determination of both K trans and v p (21) . As such, it is difficult to make simulation-based comparisons because the continuous infusion-based approach models the effects throughout the infusion process, whereas commonly used bolus-based methods generally disregard properties prior to AIF max and model the subsequent effects. And finally, histology was solely utilized for evaluating tumor morphology rather than a broader immunohistochemistry analysis to identify associations between k vasc and specific tissue properties. Comparison of dynamic MRI parameters to histology requires the reduction of a 3D active process to a 2D static state. Challenges associated with this reduction in GBM are evidenced by a previously reported absence of an association between the Gd-DTPA uptake rate constant and microvessel density (27) . As such, comparisons between histology and dynamic MRI in GBM have been largely divided into two categories: 1) associations with tumor grade (19, 58) , and 2) utilization of focal histology findings for comparison to tumor-based dynamic parameters (32, 59, 60) . Future studies may benefit from a complete multi-slice histologic analysis of tumors utilizing an array of immunohistochemistry to produce 3D multi-parameter histology maps to better understand tissue properties that influence dynamic MRI parameters.
CONCLUSION
High spatial and temporal resolution coupled with a continuous infusion-based model of the pharmacokinetics of dynamic T 1 -weighted contrast enhancement provided a quantitative measure of the effects associated with intracranial tumor-associated MVP. The musclebased RRM served as an effective surrogate for the AIF, enabling serial monitoring of tumor-associated vascular changes while obviating potential interference of tumor growth on the intracranial vessels commonly used for the AIF. Finally, the implementation of the proposed methodology on a 3T clinical scanner may broaden utilization of animal studies while also facilitating the translation of the technique to investigations of brain tumors in human patients.
SUPPORTING INFORMATION
Additional supporting information may be found in the online version of this article. Fig. S1 . Images of the phantom and associated fitted data for determination of R Fig. S2 . Parametric maps and histology images from each animal at POD 18 that correspond to images and histology from animals shown in Figures  7 and 9 . Outline of the tumor (blue) and sub-region (yellow) are identical to that depicted in Figure 9 . High-power magnifications of histology that localize to the end of each labeled line show the underlying tissue structure. In A, an area with high cellularity (a 1 ) has a similarly low k vasc value compared to an area of low cellularity (a 2 ). In B, two regions with a similar vascular distribution (b 1 and b 2 ) have differing values on the k vasc maps. In C, regions of low k vasc (c 1 ) and high k vasc (c 2 ) have a similar cellular density. At each of these corresponding locations on [Gd] maps, contrast agent accumulation is present. The black bar in the bottom right corner of each histology image represents a length of 100 mm. H&E 5 hematoxylin and eosin stain. 
